Pharmaron Beijing Co., Ltd. (3759.HK)

HKD 14.46

(7.11%)

Operating Expenses Summary of Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd.'s latest annual operating expenses in 2023 was 2.26 Billion CNY , up 13.55% from previous year.
Pharmaron Beijing Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 604.88 Million CNY , up 8.16% from previous quarter.
Pharmaron Beijing Co., Ltd. reported a annual operating expenses of 2.01 Billion CNY in annual operating expenses 2022, up 74.84% from previous year.
Pharmaron Beijing Co., Ltd. reported a annual operating expenses of 1.15 Billion CNY in annual operating expenses 2021, up 37.56% from previous year.
Pharmaron Beijing Co., Ltd. reported a quarterly operating expenses of 559.27 Million CNY for 2024 Q1, down -4.36% from previous quarter.
Pharmaron Beijing Co., Ltd. reported a quarterly operating expenses of 602.94 Million CNY for 2024 Q3, up 18.57% from previous quarter.

Annual Operating Expenses Chart of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Historical Annual Operating Expenses of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	2.26 Billion CNY	13.55%
2022	2.01 Billion CNY	74.84%
2021	1.15 Billion CNY	37.56%
2020	838.94 Million CNY	33.12%
2019	630.23 Million CNY	25.16%
2018	503.53 Million CNY	29.49%
2017	388.85 Million CNY	35.96%
2016	286 Million CNY	27.13%
2015	224.97 Million CNY	43.42%
2014	156.86 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	604.88 Million CNY	8.16%
2024 Q1	559.27 Million CNY	-4.36%
2024 Q3	602.94 Million CNY	18.57%
2023 Q1	545.18 Million CNY	-11.82%
2023 FY	2.29 Billion CNY	13.55%
2023 Q4	584.75 Million CNY	2.25%
2023 Q3	571.88 Million CNY	-2.96%
2023 Q2	589.32 Million CNY	8.1%
2022 Q1	381.86 Million CNY	12.57%
2022 FY	2.01 Billion CNY	74.84%
2022 Q4	618.27 Million CNY	11.16%
2022 Q3	556.21 Million CNY	20.53%
2022 Q2	461.45 Million CNY	20.84%
2021 FY	1.15 Billion CNY	37.56%
2021 Q4	339.23 Million CNY	4.59%
2021 Q3	324.35 Million CNY	29.46%
2021 Q1	239.92 Million CNY	-9.62%
2021 Q2	250.54 Million CNY	4.43%
2020 Q2	187.83 Million CNY	1.87%
2020 Q1	184.39 Million CNY	8.23%
2020 Q3	201.25 Million CNY	7.15%
2020 FY	838.94 Million CNY	33.12%
2020 Q4	265.46 Million CNY	31.9%
2019 Q1	146.64 Million CNY	-3.81%
2019 FY	630.23 Million CNY	25.16%
2019 Q4	170.36 Million CNY	4.95%
2019 Q3	162.33 Million CNY	7.59%
2019 Q2	150.88 Million CNY	2.89%
2018 Q1	107.04 Million CNY	18.73%
2018 FY	503.53 Million CNY	29.49%
2018 Q4	152.46 Million CNY	19.23%
2018 Q3	127.86 Million CNY	27.03%
2018 Q2	100.65 Million CNY	-5.97%
2017 Q4	90.15 Million CNY	0.0%
2017 FY	388.85 Million CNY	35.96%
2016 FY	286 Million CNY	27.13%
2015 FY	224.97 Million CNY	43.42%
2014 FY	156.86 Million CNY	0.0%

Peer Operating Expenses Comparison of Pharmaron Beijing Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-597.747%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	-206.799%